NZ318396A - Use of cationic biopolymers to produce anti-dandruff agents - Google Patents

Use of cationic biopolymers to produce anti-dandruff agents

Info

Publication number
NZ318396A
NZ318396A NZ318396A NZ31839696A NZ318396A NZ 318396 A NZ318396 A NZ 318396A NZ 318396 A NZ318396 A NZ 318396A NZ 31839696 A NZ31839696 A NZ 31839696A NZ 318396 A NZ318396 A NZ 318396A
Authority
NZ
New Zealand
Prior art keywords
chitosan
weight
germ
test
antidandruff
Prior art date
Application number
NZ318396A
Inventor
Rudolf Lehmann
Rolf Wachter
Original Assignee
Henkel Kgaa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Henkel Kgaa filed Critical Henkel Kgaa
Publication of NZ318396A publication Critical patent/NZ318396A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00Preparations for care of the hair
    • A61Q5/006Antidandruff preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73Polysaccharides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73Polysaccharides
    • A61K8/736Chitin; Chitosan; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00Preparations for care of the hair
    • A61Q5/02Preparations for cleaning the hair

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Cosmetics (AREA)

Description

<div class="application article clearfix" id="description"> <p class="printTableText" lang="en">New Zealand Paient Spedficaiion for Paient Number 318396 <br><br> New 7ealand No 318396 International No PCT/EP96/03911 <br><br> TO BE ENTERED AFTER ACCEPTANCE AND PUBLICATION <br><br> Priority dates 15 09 1995, <br><br> Complete Specification Filed 06 09 1996 <br><br> Classification (6) A61K7/06.48 <br><br> Publication date 29 September 1999 <br><br> Journal No 1444 <br><br> NO DRAWINGS <br><br> NEW ZEALAND PATENTS ACT 1953 <br><br> COMPLETE SPECIFICATION <br><br> Title of Invention <br><br> Use of cationic biopolymers to produce anti-dandruff agents <br><br> Name, address and nationality of applicant(s) as in international application form <br><br> HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN, 40191 Dusseldorf, Germany <br><br> V " <br><br> A <br><br> £ * f»rv t? <br><br> The Use of Chitosans for the Production of Antidandruff Formulations <br><br> Field of the Invention <br><br> This invention relates to the use of chitosan for the production of antidandruff formulations and to antidandruff formulations comprising chitosan Divisional specification no N2 336633 relates to the use of chitosan for destroying yeasts and to antithrush formulations <br><br> Prior Art <br><br> 5 "Scales" is the colloquial term for those parts of the homy layer of the skin which are shed during the constant renewal of the skin layers On the hair-covered head, scales are clearly visible as a result of amalgamation by tallow and perspiration into relatively large aggregates Cosmetically unattractive squamation of the scalp, which can be caused by a number of 10 pathological yeasts and which is generally accompanied by more or less intensive itching, has hitherto been tackled by treatment with antidandruff shampoos containing, for example, selenium compounds, pynthione salts or glucocorticosteroids as ingredients (cf S Shuster in Br J. Dermatol., 111, 235 (1984) and Cosmet Toil , 103, 87 (1988) <br><br> 15 Now, neither selenium nor pynthione salts are among the more dermatologically compatible ingredients of hair treatment formulations More specifically, this means that they have a certain sensitizing potential and, because of this, can cause irritation in particularly sensitive users On <br><br> H 2059 <br><br> 2 <br><br> cases wnere desquamation has been aggravated by illness Accordingly, the problem addressed by the present invention was to provide new active ingredients for antidandruff formulations which would act against yeasts, would reduce scaling of the scalp and at the same time would show improved <br><br> 5 dermatological compatibility, and or at least to provide the public with a useful choice <br><br> Description of the Invention <br><br> The present invention relates to the use of chitosan for the production of <br><br> 1 n antidandruff formulations <br><br> It has surprisingly been found that, even in very small quantities, chitosan reduces suspensions of various yeasts to germ contents below 10/g in four hours Accordingly, when the chitosan solutions are applied to the scalp, le for example where they form part of a hair treatment formulations, desquamation can be significantly reduced The invention includes the observation that, in addition, chitosans show particularly high dermatological compatibility which makes them suitable for use on the scalp <br><br> 15 <br><br> 20 Chitosans belong to the group of hydrocolloids Chemically, they are generally partly deacetylated chitins - or derivatives thereof - varying in molecular weight which contain the idealized monomer unit (I) <br><br> 25 <br><br> (I) <br><br> OH NHo CH-&gt;OH <br><br> £ - L <br><br> H 2059 3 t <br><br> In contrast to most hydrocolloids, which are negatively charged at biological pH values, chitosans and their derivatives are cationic compounds under these conditions The positively charged biopolymers are capable of interacting with oppositely charged surfaces and, accordingly, are used in 5 cosmetic hair-care and body-care formulations and also as thickeners in amphoteric/catiomc surfactant mixtures Reviews on this subject have been published, for example, by B Gesslein et al in HAPP1 27, 57 (1990), by 0 Skaugrud in Drug Cosm Ind 148, 24 (1991) and by E Onsoyen et al in Seifen-Ole-Fette-Wachse 117. 633 (1991) Chitosans are produced from 10 chitin, preferably from the shell remains of crustaceans which are available in large quantities as inexpensive raw materials Normally, the chitin is first deproteinized by addition of bases, demineralized by addition of mineral acids and, finally, deacetylated by addition of strong bases, the molecular weights being spread over a broad range Corresponding processes for the 15 production of - microcrystalline - chitosan are described, for example, in WO 91/05808 (Firextra Oy) and in EP-B1 0 382 150 (Hoechst) Besides cationic biopolymers of the chitosan type, derivatives, especially hydroxypropyl chitosans, may also be used as starting materials for the production of the antidandruff formulations The quantities used may be in the range from 0 01 20 to 3% by weight and are preferably in the range from 0 05 to 1 % by weight and more preferably in the range from 0 1 to 0 5% by weight, based on the formulation <br><br> Commercial Applications <br><br> 25 Chitosans are not only particularly compatible with the skin, they also kill off the yeasts responsible for the excessive formation of head scales such as, for example, Candida albicans or Mallassezia furfur (which was previously know by the name of Pityrosporum ovale) both quickly and reliably Accordingly, they are particularly advaniageous active substances for the production of antidandruff formulations Their use for the destruction of yeasts is the subject qn of divisional specification no NZ 336633 which also includes occlusive application on the skin or mucous membrane, for examplej/or^fMirl^thrushij <br><br> " 6 AUG 1SS9 <br><br> - - i r,( r <br><br> NZ <br><br> RECEIVED <br><br> Antidandruff formulations <br><br> The antidandruff formulations may contain surfactants compatible with their other ingredients Typical examples are fatty alcohol polyglycol ether sulfates, monoglycende sulfates, mono- and/or dialkyi sulfosuccinates, fatty acid isethionates, fatty acid sarcosinates, fatty acid taurides, ether carboxylic acids, alkyl oligoglucosides, fatty acid glucamides, alkyl amidobetaines and/or vegetable protein fatty acid condensates <br><br> The formulations, which are preferably shampoos or conditioners, may also contain oils, emulsifiers, superfatting agents, thickeners, cationic polymers, silicone compounds, biogenic agents, film formers, preservatives, dyes and fragrances as further auxiliaries and additives <br><br> Suitable oils are, for example, Guerbet alcohols based on fatty alcohols containing 6 to 18 and preferably 8 to 10 carbon atoms, esters of linear fatty acids with linear C^o fatty alcohols, esters of branched C^3 carboxylic acids with linear fatty alcohols, esters of linear Cg.^ fatty acids with branched alcohols, more particularly 2-ethyl hexanol, esters of linear and/or branched fatty acids with polyhydric alcohols (for example dimer diol or trimer diol) and/or Guerbet alcohols, triglycerides based on C^o fatty acids, vegetable oils, branched primary alcohols, substituted cyclohexanes, Guerbet carbonates, dialkyi ethers and/or aliphatic or naphthenic hydrocarbons <br><br> Nonionic, ampholyte and/or zwitterionic surface-active compounds distinguished by a lipophilic, preferably linear, alkyl or alkenyl group and at least one hydrophilic group may be used as emulsifiers or co-emulsifiers The hydrophilic group may be both an ionic group and a nonionic group Nonionic emulsifiers contain, for example, a polyol group, a polyalkylene glycol ether group or a combination of a polyol and a polyglycol ether group <br><br> WO 97/09961 5 PCT/EP96/03911 <br><br> as the hydrophilic group <br><br> Preferred formulations are those containing nonionic surfactants from at least one of the following groups as o/w emulsifiers (a1) adducts of 2 to 30 moles of ethylene oxide and/or 0 to 5 moles of propylene oxide with linear 5 fatty alcohols containing 8 to 22 carbon atoms, with fatty acids containing 12 to 22 carbon atoms and with alkylphenols containing 8 to 15 carbon atoms in the alkyl group, (a2) C12/18 fatty acid monoesters and diesters of adducts of 1 to 30 moles of ethylene oxide with glycerol, (a3) glycerol monoesters and diesters and sorbitan monoesters and diesters of saturated and unsaturated 10 fatty acids containing 6 to 22 carbon atoms and ethylene oxide adducts thereof, (a4) alkyl mono- and -oligoglycosides containing 8 to 22 carbon atoms in the alkyl radical and ethoxylated analogs thereof and (a5) adducts of 15 to 60 moles of ethylene oxide with castor oil and/or hydrogenated castor oil, (a6) polyol and in particular polyglycerol esters such as, for example, 15 polyglycerol polyricinoleate or polyglycerolpoly-12-hydroxystearate Mixtures of compounds from several of these classes are also suitable The addition i <br><br> products of ethylene oxide and/or propylene oxide with fatty alcohols, fatty acids, alkylphenols, glycerol monoesters and diesters and sorbitan monoesters and diesters of fatty acids or with castor oil are known commercially 20 available products They are homolog mixtures of which the average degree of alkoxylation corresponds to the ratio between the quantities of ethylene oxide and/or propylene oxide and substrate with which the addition reaction is earned out C12/18 fatty acid monoesters and diesters of adducts of ethylene oxide with glycerol are known as refatting agents for cosmetic formulations 25 from DE-PS 20 24 051 alkyl mono- and oligoglycosides, their production and their use as surfactants are known, for example, from US 3,839,318, US 3,707,535, US 3,547,828, DE-OS 19 43 689, DE-OS 20 36 472 and DE-A1 30 01 064 and also from EP-A 0 077 167 They are produced in particular by reacting glucose or oligosaccharides with primary 30 C8/18 alcohols So far as the glycoside unit is concerned, both monoglyco- <br><br> WO 97/0S961 6 PCT/EP96/03911 <br><br> sides in which a cyclic sugar unit is attached to the fatty alcohol by a glycoside bond and oligomeric glycosides with a degree of oligomerization of preferably up to about 8 are suitable The degree of oligomerization is a statistical mean value on which the homolog distribution typical of such technical products is based In addition, zwitterionic surfactants may be used as emulsifiers Zwitterionic surfactants are surface-active compounds which contain at least one quaternary ammonium group and at least one carboxylate and one sulfonate group in the molecule Particularly suitable zwitterionic surfactants are the so-called betaines, such as the N-alkyl-N,N-dimethyl ammonium glycinates, for example cocoalkyl dimethyl ammonium glycinate, N-acylaminopropyl-N,N-dimethyl ammonium glycinates, for example cocoacylaminopropyl dimethyl ammonium glycinate, and 2-alkyl-3-carboxymethyl-3-hydroxyethyl imidazolines containing 8 to 18 carbon atoms in the alkyl or acyl group and cocoacylaminoethyl hydroxyethyl carboxymethyl glycinate The fatty acid amide derivative known under the CTFA name of Cocoamidopropyl Betaine is particularly preferred Ampholytic surfactants are also suitable emulsifiers Ampholytic surfactants are surface-active compounds which, in addition to a Cms alkyl or acyl group, contain at least one free amino group and at least one -COOH- or -S03H- group in the molecule and which are capable of forming inner salts Examples of suitable ampholytic surfactants are N-alkyl glycines, N-alkyl propionic acids, N-alkylaminobutyric acids, N-alkyliminodipropionic acids, N-hydroxyethyl-N-alkylamidopropyl glycines, N-alkyl taurines, N-alkyl sarcosines, 2-alkyl-aminopropionic acids and alkylaminoacetic acids containing around 8 to 18 carbon atoms in the alkyl group Particularly preferred ampholytic surfactants are N-cocoalkylaminopropionate, cocoacylaminoethyl aminopropionate and C12/18 acyl sarcosine <br><br> Suitable w/o emulsifiers are (b1) adducts of 2 to 15 moles of ethylene oxide with castor oil and/or hydrogenated castor oil, (b2) partial esters based on linear, branched, unsaturated or saturated C12/22 fatty acids, <br><br> WO 97/09961 7 PCT/EP96/03911 <br><br> ricinoleic acid and 12-hydroxystearic acid and glycerol, polyglycerol, penta-erythritol, dipentaerythritol, sugar alcohols (for example sorbitol) and polyglu-cosides (for example cellulose), (b3) trialkyl phosphates, (b4) wool wax alcohols, (b5) polysiloxane/polyalkyl polyether copolymers and corresponding derivatives, (b6) mixed esters of pentaerythritol, fatty acids, citric acid and fatty alcohol according to DE-PS 11 65 574 and (b7) polyalkylene glycols <br><br> Superfatting agents may be selected from such substances as, for example, polyethoxylated lanolin derivatives, lecithin derivatives, polyol fatty acid esters, monoglycendes and fatty acid alkanolamides, the fatty acid alkanolamides also serving as foam stabilizers Suitable thickeners are, for example, polysaccharides, more especially xanthan gum, guar-guar, agar-agar, alginates and tyloses, carboxymethyl cellulose and hydroxyethyl cellulose, also relatively high molecular weight polyethylene glycol monoesters and diesters of fatty acids, polyacrylates, polyvinyl alcohol and polyvinyl pyrrohdone, surfactants such as, for example, narrow-range fatty alcohol ethoxylates or alkyl oligoglucosides and electrolytes, such as sodium chloride and ammonium chloride <br><br> Suitable cationic polymers are, for example, cationic cellulose derivatives, cationic starch, copolymers of diallyl ammonium salts and acrylamides, quaternized vinyl pyrrolidone/vinyl imidazole polymers such as, for example, Luviquat® (BASF AG, Ludwigshafen, FRG), condensation products of polyglycols and amines, quaternized collagen polypeptides such as, for example, Lauryldimonium Hydroxypropyl Hydrolyzed Collagen (Lame-quat®L, Grunau GmbH), polyethyleneimine, cationic silicone polymers such as, for example, Amidomethicone or Dow Corning, Dow Corning Co , USA, copolymers of adipic acid and dimethylaminohydroxypropyl diethylene-triamine (Cartaretine®, Sandoz AG, CH), polyaminopolyamides as described, for example, in FR-A 2 252 840 and crosslinked water-soluble polymers thereof, cationic chitin derivatives such as, for example, quaternized chitosan, optionally in microcrystalline distribution, cationic guar gum such as, for <br><br> H 2059 8 <br><br> example, Jaguar®CBS, Jaguar®C-17, Jaguar®C-16 of Celanese, USA, quaternized ammonium salt polymers such as, for example, Mirapol® A-15, Mirapol® AD-1, Mirapol® AZ-1 of Miranol, USA <br><br> Suitable silicone compounds are, for example, dimethyl polysilox-5 anes, methylphenyl polysiloxanes, cyclic silicones and amino-, fatty-acid-, alcohol-, polyether-, epoxy-, fluorine- and/or alkyl-modified silicone compounds In the context of the invention, biogenic agents are, for example, plant extracts and vitamin complexes Conventional film formers are, for example, chitosan, microcrystalline chitosan, quaternized chitosan, polyvinyl 10 pyrrolidone, vinyl pyrrolidone/vinyl acetate copolymers, polymers of the acrylic acid series, quaternary cellulose derivatives, collagen, hyaluronic acid or salts thereof and similar compounds Suitable preservatives are, for example, phenoxyethanol, formaldehyde solution, parabens, pentanediol or sorbic acid Suitable pearlescers are, for example, glycol distearic acid 15 esters, such as ethylene glycol distearate, and also fatty acid monoglycol esters The dyes used may be selected from any of the substances which are licensed and suitable for cosmetic purposes, as listed for example in the publication "Kosmetische Farbemittel" of the Farbstoffkommission der Deutschen Forschungsgemeinschaft, published by Verlag Chemie, 20 Weinheim, 1984, pages 81-106 These dyes are normally used in concentrations of 0 001 to 0 1 % by weight, based on the mixture as a whole In all, the auxiliaries and additives may make up 1 to 50 and preferably 5 to 40% by weight of the formulations <br><br> The following Examples are intended to illustrate the invention without 25 limiting it in any way <br><br> Examples <br><br> A quantitative suspension test was carried out with the corresponding test germs to determine germicidal activity A chitosan (Hydagen® 30 CMF, Henkel KGaA, Dusseldorf/FRG) in the form of a 1 % by weight solution <br><br></p> </div>

Claims (7)

  1. <div class="application article clearfix printTableText" id="claims">
    <p lang="en">
    WO 97/09961 9 PCT/EP96/03911<br><br>
    in demineralized water containing an addition of 0 7% by weight of benzoic acid (Examples 1 and 2) or 0 4% by weight of glycolic acid (Examples 3 and 4) was used for this test The test germs used were the yeasts Candida albicans ATCC 10231 and Malassezia furfur (= Pityrosporum ovale) 0 1 ml of the yeast suspensions was added to and thoroughly mixed with 10 g of the test samples After an incubation period of 4 h to 7 d, the germ content in the mixtures was determined The results are set out in Table 1 below<br><br>
    Table 1<br><br>
    Germ destruction with cationic biopolymers<br><br>
    Example<br><br>
    Test germ, germ count/ml<br><br>
    Germ content after contact time<br><br>
    4 h<br><br>
    1 d<br><br>
    3 d<br><br>
    7 d<br><br>
    1<br><br>
    Candida albicans 48 * 10®<br><br>
    &lt; 10<br><br>
    &lt; 10<br><br>
    &lt; 10<br><br>
    &lt; 10<br><br>
    2<br><br>
    Malassezia furfur 1 8 * 107<br><br>
    &lt; 10<br><br>
    &lt; 10<br><br>
    &lt; 10<br><br>
    &lt; 10<br><br>
    3<br><br>
    Candida albicans 4 8 * 108<br><br>
    &lt; 10<br><br>
    &lt; 10<br><br>
    &lt; 10<br><br>
    &lt; 10<br><br>
    4<br><br>
    Malassezia furfur 1 8 MO7<br><br>
    2*104<br><br>
    &lt; 10<br><br>
    &lt; 10<br><br>
    &lt; 10<br><br>
    10<br><br>
    WHAT WE CLAIM IS,<br><br>
    1 The use of chitosan for the production of antidandruff formulations<br><br>
  2. 2 The use claimed in claim 1, characterised in that the chitosan is used in quantities of 0 01-3% by weight<br><br>
  3. 3 An antidandruff formulation comprising an effective amount of chitosan together with a pharmaceutical^ acceptable carrier<br><br>
  4. 4 An antidandruff formulation according to claim 3, wherein the chitosan is present in quantities of 0 01-3% by weight.<br><br>
  5. ©TO OP CLAIMS<br><br>
  6. </p>
  7. </div>
NZ318396A 1995-09-15 1996-09-06 Use of cationic biopolymers to produce anti-dandruff agents NZ318396A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19534370A DE19534370C2 (en) 1995-09-15 1995-09-15 Use of cationic chitosan
PCT/EP1996/003911 WO1997009961A1 (en) 1995-09-15 1996-09-06 Use of cationic biopolymers to produce anti-dandruff agents

Publications (1)

Publication Number Publication Date
NZ318396A true NZ318396A (en) 1999-09-29

Family

ID=7772345

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ318396A NZ318396A (en) 1995-09-15 1996-09-06 Use of cationic biopolymers to produce anti-dandruff agents

Country Status (10)

Country Link
EP (1) EP0850041A1 (en)
JP (1) JPH11512408A (en)
KR (1) KR19990044668A (en)
CN (1) CN1195978A (en)
AU (1) AU712218B2 (en)
CA (1) CA2232422A1 (en)
DE (1) DE19534370C2 (en)
NO (1) NO980175D0 (en)
NZ (1) NZ318396A (en)
WO (1) WO1997009961A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1392306A (en) * 2001-06-15 2003-01-22 张文忠 Fabric processing method after washing
EP1384404A1 (en) * 2002-07-23 2004-01-28 The Procter & Gamble Company Hair care compositions
FR3039765B1 (en) * 2015-08-07 2018-08-24 Oreal COSMETIC PROCESS FOR TREATING KERATINIC MATERIALS

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA82301B (en) * 1981-01-31 1982-12-29 Beecham Group Plc Medicated conditioner
CA1197785A (en) * 1981-09-14 1985-12-10 David A. Glover Anti-dandruff cream rinse conditioner
US4701444A (en) * 1984-08-28 1987-10-20 Ramot University Authority For Applied Research And Industrial Development Ltd. Topical pharmaceutical preparations containing chitin soluble extract
CA1261264A (en) * 1984-11-29 1989-09-26 Shigeo Suzuki Immunopotentiating agents and method
DE3513277A1 (en) * 1985-04-13 1986-10-23 Wella Ag, 6100 Darmstadt COSMETIC AGENTS BASED ON QUATERNAUS HYDROXYALKYL-SUBSTITUTED CHITOSAN DERIVATIVES
DE3614697A1 (en) * 1986-04-30 1987-11-05 Wella Ag COSMETIC AGENTS BASED ON N-HYDROXYBUTYL-CHITOSANS, NEW N-HYDROXYBUTYL-CHITOSANS AND METHODS FOR THE PRODUCTION THEREOF
JPH0753876B2 (en) * 1986-12-11 1995-06-07 ライオン株式会社 Cleaning composition
JPS6416714A (en) * 1987-07-08 1989-01-20 Nanyo Kasei Kk Bathing agent
JPS6468844A (en) * 1987-09-09 1989-03-14 Nec Corp Service processor
JPH0813260B2 (en) * 1988-06-09 1996-02-14 株式会社上野製薬応用研究所 How to store food

Also Published As

Publication number Publication date
DE19534370C2 (en) 1998-04-02
WO1997009961A1 (en) 1997-03-20
EP0850041A1 (en) 1998-07-01
AU6987396A (en) 1997-04-01
CA2232422A1 (en) 1997-03-20
JPH11512408A (en) 1999-10-26
KR19990044668A (en) 1999-06-25
NO980175L (en) 1998-01-14
DE19534370A1 (en) 1997-03-20
CN1195978A (en) 1998-10-14
NO980175D0 (en) 1998-01-14
AU712218B2 (en) 1999-11-04

Similar Documents

Publication Publication Date Title
US5962663A (en) Cationic biopolymers
EP0570532B1 (en) Quaternized panthenol compounds and their use
EP1891924B1 (en) Composition for protection of body surface
JP3721424B2 (en) Cosmetic preparation
EP0550276B1 (en) Compositions comprising anionic glycolipid surfactants
JP2003515547A (en) Modified starch solutions and their use in personal care
JP2001503440A (en) Cosmetic preparation
KR20130088057A (en) Compositions
JPH09221503A (en) Biopolymer improved in solubility in surfactant
US4603048A (en) Acid tenside-anion solution of chitosan and its use in cosmetic preparations
KR20190050815A (en) Protein hydrolyzate
JP2003514046A (en) Method for producing nanoparticulate chitosan or chitosan derivative
JP2002510337A (en) Chitosan microspheres
CA2001271A1 (en) Preserved hair and body care products and the use of a combination of preservatives
DE60101486T2 (en) Use of polyamino acid derivatives as a preservative
AU712218B2 (en) The use of cationic biopolymers for the production of antidandruff formulations
US2460776A (en) Bacteriostatic base for medicinal, cosmetic, and toilet preparations
JP3946263B2 (en) Collagen-free cosmetics produced from cross-linked chitosan hydrogel
KR20050120635A (en) Low irritation lathering formulation
JP2002532528A (en) Deodorant cosmetic preparation
JPH11508571A (en) Cosmetic preparation for hair containing cationic biopolymer
JP3656780B2 (en) Cosmetic composition, method for producing the same, and cosmetics containing the same
US20040018165A1 (en) Hair care compositions
JP3389680B2 (en) Detergent composition
JPH0532995A (en) Detergent composition